These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 21684285)

  • 21. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.
    Wu CY; Carpenter ES; Takeuchi KK; Halbrook CJ; Peverley LV; Bien H; Hall JC; DelGiorno KE; Pal D; Song Y; Shi C; Lin RZ; Crawford HC
    Gastroenterology; 2014 Dec; 147(6):1405-16.e7. PubMed ID: 25311989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant
    Shen J; Ha DP; Zhu G; Rangel DF; Kobielak A; Gill PS; Groshen S; Dubeau L; Lee AS
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E4020-E4029. PubMed ID: 28461470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and manipulation of biliary metaplasia in pancreatic tumors.
    Delgiorno KE; Hall JC; Takeuchi KK; Pan FC; Halbrook CJ; Washington MK; Olive KP; Spence JR; Sipos B; Wright CV; Wells JM; Crawford HC
    Gastroenterology; 2014 Jan; 146(1):233-44.e5. PubMed ID: 23999170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
    Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT
    Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch1 is not required for acinar-to-ductal metaplasia in a model of Kras-induced pancreatic ductal adenocarcinoma.
    Avila JL; Troutman S; Durham A; Kissil JL
    PLoS One; 2012; 7(12):e52133. PubMed ID: 23284900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
    Jin K; Park S; Ewton DZ; Friedman E
    Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
    Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
    Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic STAT5 activation promotes Kras
    Lin Y; Pu S; Wang J; Wan Y; Wu Z; Guo Y; Feng W; Ying Y; Ma S; Meng XJ; Wang W; Liu L; Xia Q; Yang X
    Gut; 2024 Oct; 73(11):1831-1843. PubMed ID: 38955401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
    Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
    Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.
    Nishikawa Y; Kodama Y; Shiokawa M; Matsumori T; Marui S; Kuriyama K; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Ota Y; Maruno T; Uza N; Uesugi M; Kageyama R; Chiba T; Seno H
    Oncogene; 2019 May; 38(22):4283-4296. PubMed ID: 30705405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
    Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR
    Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer.
    Azizi N; Toma J; Martin M; Khalid MF; Mousavi F; Win PW; Borrello MT; Steele N; Shi J; di Magliano MP; Pin CL
    Oncogene; 2021 Apr; 40(17):3118-3135. PubMed ID: 33864001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.
    Zhang Z; Li H; Deng Y; Schuck K; Raulefs S; Maeritz N; Yu Y; Hechler T; Pahl A; Fernández-Sáiz V; Wan Y; Wang G; Engleitner T; Öllinger R; Rad R; Reichert M; Diakopoulos KN; Weber V; Li J; Shen S; Zou X; Kleeff J; Mihaljevic A; Michalski CW; Algül H; Friess H; Kong B
    Gastroenterology; 2021 Nov; 161(5):1601-1614.e23. PubMed ID: 34303658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciliogenesis and Hedgehog signalling are suppressed downstream of KRAS during acinar-ductal metaplasia in mouse.
    Bangs FK; Miller P; O'Neill E
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32571902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
    Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
    Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
    Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
    J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia.
    Zhu L; Shi G; Schmidt CM; Hruban RH; Konieczny SF
    Am J Pathol; 2007 Jul; 171(1):263-73. PubMed ID: 17591971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.